Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: A Study of EMB-02 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
The clinical trial of EMB-02 for advanced solid tumors (Phase 1/2) has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-05-20Clinical Trial Update: Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors [Phase 3]
Phase 3 trial evaluating prophylactic antiviral therapy in patients with current or past hepatitis B infection receiving anti-cancer therapy…
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: A Phase 1 Study to Investigate Axatilimab Alone or in Combination With Durvalumab in Patients With Solid Tumors [Phase 1]
A Phase 1 study evaluating Axatilimab alone or in combination with Durvalumab in patients with solid tumors has completed.
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: A Study of FDA022-BB05 in Subjects With Advanced Solid Malignant Tumors [Phase 1]
A Phase 1 trial evaluating FDA022-BB05 in patients with advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: TR115 in Patients With Relapsed / Refractory Non-Hodgkin's Lymphoma or Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial of TR115 is currently recruiting in patients with relapsed/refractory non-Hodgkin's lymphoma and advanced solid tum…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-05-08Clinical Trial Update: A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
The phase 1/2 trial of MDK-703 in patients with solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: ONO-4538 Phase I Study in Patients With Solid Tumor [Phase 1]
Phase I study of ONO-4538 (nivolumab) in patients with solid tumors has completed. The sponsor is Ono Pharmaceutical Co., Ltd.
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update evaluating safety, pharmacodynamics, and pharmacokinetics of the IV study drug QN-302 in patients with advance…
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: A Study of RC88 Combined With Sintilimab for Advanced Solid Tumours [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating RC88 in combination with Sintilimab for advanced solid tumors, and the study is currently recruitin…
-
CLINICAL_TRIALS research · 2024-04-15Clinical Trial Update: Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TJ107 in Chinese Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of TJ107 in Chinese patients with advanced solid tumo…
-
CLINICAL_TRIALS trial_result · 2024-04-05Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts [Phase 2]
Phase 2 clinical trial update evaluating safety, pharmacokinetics, and clinical effects of IV PT-112 in advanced solid tumors with dose expa…
-
CLINICAL_TRIALS trial_result · 2024-03-19Clinical Trial Update: Durvalumab and Tremelimumab for Pediatric Malignancies [Phase 1, Phase 2]
Phase 1/2 trial evaluating durvalumab and tremelimumab in pediatric malignancies has results posted; the study is currently active but not r…
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN [Phase 2]
Phase II, single-center randomized open-label trial evaluating the impact of serial procalcitonin measurements in patients with hematologic …
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Basket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations [Phase 2]
Phase 2 basket study of neratinib in solid tumors with somatic HER2 or EGFR exon 18 mutations was terminated; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-03-07Clinical Trial Update: Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101 [Phase 1]
Phase 1 trial of intratumorally administered STING agonist E7766 in advanced solid tumors or lymphomas has been terminated with results post…
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: A Study Of PF-04449913 Administered Alone In Select Solid Tumors [Phase 1]
Phase 1 trial evaluating PF-04449913 as a single agent in select solid tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-05Clinical Trial Update: A Dose Escalation and Cohort Expansion Study of Subcutaneously-Administered Cytokine ALKS 4230 (Nemvaleukin Alfa) as a Single Agent and in Combination With Anti-PD-1 Antibody (Pembrolizumab) in Subjects With Select Advanced or Metastatic Solid Tumors (ARTISTRY-2) [Phase 1, Phase 2]
A dose-escalation and cohort-expansion study of subcutaneously administered nemvaleukin alfa (ALKS 4230), alone and with pembrolizumab, in a…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Study of Ulevostinag (MK-1454) Alone or in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001) [Phase 1]
Phase 1 study of Ulevostinag (MK-1454) alone or in combination with pembrolizumab (MK-3475) in participants with advanced/metastatic solid t…
-
CLINICAL_TRIALS trial_result · 2024-02-23Clinical Trial Update: Phase I/Ib Multiple Ascending Dose Study in China [Phase 1]
Phase I/Ib multiple ascending dose trial in China for metastatic solid tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-02-22Clinical Trial Update: This Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Metastatic Solid Tumors. [Phase 1, Phase 2]
Phase 1/2 trial evaluating OBI-888 for safe and effective dosing in patients with locally advanced or metastatic solid tumors; the study is …
-
CLINICAL_TRIALS trial_result · 2024-02-22Clinical Trial Update: Nivolumab Ipilimumab in Patients With hyperMutated Cancers Detected in Blood (NIMBLe) [Phase 2]
Phase 2 trial of nivolumab plus ipilimumab in patients with hypermutated cancers detected in blood (NIMBLe) was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2024-02-09Clinical Trial Update: A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors [Phase 1, Phase 2]
Phase Ib/II trial updates the combination of GT90001 with KN046 in solid tumors, with phase progression in early development.
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Participants With Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of CEP-9722 (PARP inhibitor) in solid tumors was terminated; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL [Phase 1, Phase 2]
Phase 1/2 trial update for CX-2029 in solid tumors and DLBCL completed; aims to identify safe and active dose levels.
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: A Study of BLZ945 Single Agent or BLZ945 in Combination With PDR001 in Advanced Solid Tumors [Phase 1, Phase 2]
A phase 1/2 trial evaluating BLZ945 alone or with PDR001 in advanced solid tumors was terminated; results posted.